nalfurafine hydrochloride (TRK-820)

DRUG2 trials

Sponsors

Toray Industries, Inc, SK Chemicals Co., Ltd.

Conditions

Conventional-treatment-resistant Pruritus in Patients Receiving HemodialysisPruritus With Chronic Liver Disease

Phase 2

Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients With Chronic Liver Disease -

CompletedNCT00638495

Toray Industries, IncPruritus With Chronic Liver Disease

Start: 2008-03-31End: 2009-12-31Target: 120Updated: 2010-02-01

Phase 3

Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

CompletedNCT01513161

SK Chemicals Co., Ltd.Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis

Start: 2008-04-30End: 2009-10-31Updated: 2012-01-20